A meta‐analysis that was published in 2010 including 40 studies reported that AD patients had increased circulating blood levels for TNF‐α, transforming growth factor beta (TGF‐β), IL 1 beta (IL‐1β), IL‐6, IL‐12, and IL‐18.7 Here, IL1B is linked to Alzheimer disease.